Search Articles

Telehealth Rehabilitation for Cognitive Impairment: Randomized Controlled Feasibility Trial

Cognitive rehabilitation is a promising but understudied nonpharmacological individualized treatment that has been shown to help individuals with mild cognitive impairment (MCI), early stage dementia due to Alzheimer disease (AD), and vascular dementia set

Rachel L Burton, Megan E O'Connell

JMIR Res Protoc 2018;7(2):e43

Download Citation: END BibTex RIS

The Impact of the Virtual Cognitive Health Program on the Cognition and Mental Health of Older Adults: Pre-Post 12-Month Pilot Study

These individuals are considered at-risk for developing dementia, particularly Alzheimer disease (AD) [5-7].

Shefali Kumar, Jennifer LA Tran, Heidi Moseson, Caroline Tai, Jordan M Glenn, Erica N Madero, Caitlyn Krebs, Nicholas Bott, Jessie L Juusola

JMIR Aging 2018;1(2):e12031

Download Citation: END BibTex RIS

Diabetes-Related Topics in an Online Forum for Caregivers of Individuals Living With Alzheimer Disease and Related Dementias: Qualitative Inquiry

IntroductionBackgroundDiabetes and Alzheimer disease and related dementias (ADRD) are the seventh and sixth leading causes of death in the United States, respectively, and they coexist in many older adults [1,2].

Yan Du, Kristi Paiva, Adrian Cebula, Seon Kim, Katrina Lopez, Chengdong Li, Carole White, Sahiti Myneni, Sudha Seshadri, Jing Wang

J Med Internet Res 2020;22(7):e17851

Download Citation: END BibTex RIS

Study of the Usability of Spaced Retrieval Exercise Using Mobile Devices for Alzheimer’s Disease Rehabilitation

Ahmad Zmily, Yaser Mowafi, Ehab Mashal

JMIR Mhealth Uhealth 2014;2(3):e31

Download Citation: END BibTex RIS

Comparing Crowdsourcing and Friendsourcing: A Social Media-Based Feasibility Study to Support Alzheimer Disease Caregivers

Alzheimer disease (AD) accounts for the majority of cases of dementia in the United States [2]. Unlike for many other diseases, to date there are no disease-modifying agents to slow down or stop the progression of AD.

Daniel Robert Bateman, Erin Brady, David Wilkerson, Eun-Hye Yi, Yamini Karanam, Christopher M Callahan

JMIR Res Protoc 2017;6(4):e56

Download Citation: END BibTex RIS

Current State of Digital Biomarker Technologies for Real-Life, Home-Based Monitoring of Cognitive Function for Mild Cognitive Impairment to Mild Alzheimer Disease and Implications for Clinical Care: Systematic Review

Digital Biomarkers DevelopmentTo aid in the more precise assessment of patients, clinicians increasingly use biological and imaging biomarkers (eg, cerebrospinal fluid and positron emission tomography) to determine the patient’s particular risk for developing Alzheimer

Antoine Piau, Katherine Wild, Nora Mattek, Jeffrey Kaye

J Med Internet Res 2019;21(8):e12785

Download Citation: END BibTex RIS

Artificial Intelligence for Caregivers of Persons With Alzheimer’s Disease and Related Dementias: Systematic Literature Review

Bo Xie, Cui Tao, Juan Li, Robin C Hilsabeck, Alyssa Aguirre

JMIR Med Inform 2020;8(8):e18189

Download Citation: END BibTex RIS

A Comprehensive Evaluation of the Process of Copying a Complex Figure in Early- and Late-Onset Alzheimer Disease: A Quantitative Analysis of Digital Pen Data

IntroductionBackgroundThe Rey-Osterrieth Complex Figure Test (RCFT) is widely used to examine the visuoconstruction and visual memory function of patients with brain injuries or cognitive impairment such as Alzheimer disease (AD) [1].

Ko Woon Kim, Sung Yun Lee, Jongdoo Choi, Juhee Chin, Byung Hwa Lee, Duk L Na, Jee Hyun Choi

J Med Internet Res 2020;22(8):e18136

Download Citation: END BibTex RIS

Using Big Data to Estimate Dementia Prevalence in New Zealand: Protocol for an Observational Study

It contains information on about 250 demographic, clinical (including the diagnosis of Alzheimer disease and dementia), and psychosocial factors, which can be used to support care planning, resource allocation, quality measurement, and outcome evaluation.

Claudia Rivera-Rodriguez, Gary Cheung, Sarah Cullum

JMIR Res Protoc 2021;10(1):e20225

Download Citation: END BibTex RIS

Categorizing Health Outcomes and Efficacy of mHealth Apps for Persons With Cognitive Impairment: A Systematic Review

disease, and dementia offer a unique opportunity for intervention because there are no disease-modifying agents for Alzheimer disease and related dementias [7].

Daniel R Bateman, Bhavana Srinivas, Thomas W Emmett, Titus K Schleyer, Richard J Holden, Hugh C Hendrie, Christopher M Callahan

J Med Internet Res 2017;19(8):e301

Download Citation: END BibTex RIS